SCHEMBL9505934

SCHEMBL9505934

CC(=O)OC1C(=O)N(CCN(C)C)c2ccccc2SC1c1ccccc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1S Q13698 6/20 0.84
CYP3A4 P08684 3/20 0.84
TSHR P16473 2/20 0.84
ABCB11 O95342 2/20 0.84
LMNA P02545 2/20 0.84
KCNH2 Q12809 2/20 0.84
SLC22A1 O15245 1/20 0.84
CACNA1F O60840 1/20 0.84
ABCB1 P08183 1/20 0.84
HRH2 P25021 1/20 0.84
ADRA1A P35348 1/20 0.84
SCN1A P35498 1/20 0.84
SCN4A P35499 1/20 0.84
HTT P42858 1/20 0.84
SCN7A Q01118 1/20 0.84
CACNA1D Q01668 1/20 0.84
PLAUR Q03405 1/20 0.84
CACNA1C Q13936 1/20 0.84
SCN5A Q14524 1/20 0.84
SCN9A Q15858 1/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22512416 1.00 CACNA1S (0.84) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL1938351 0.93 CACNA1S (0.80) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL10330283 0.93 CACNA1S (0.82) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL22269192 0.93 CACNA1S (0.82) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL9505009 0.93 CYP3A4 (0.75) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL13273508 0.93 CACNA1S (0.82) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL19568199 0.93 CACNA1S (0.82) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL12557663 0.93 CACNA1S (0.82) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL16588915 0.92 CYP3A4 (0.83) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL9506858 0.92 CYP3A4 (0.83) CACNA1SCYP3A4TSHRABCB11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0279425-B1 USE OF BENZOTHIAZEPINE DERIVATIVES, IN PARTICULAR DILTIAZEM, IN THE MANUFACTURE OF MEDICAMENTS TO PROTECT LYMPHOCYTES GÖDECKE AKTIENGESELLSCHAFT (DE) 1993-08-04 EP disclosed
US-4861770-A Use of benzothiazepine derivatives as lymphocyte protectors GOEDECKE AKTIENGESELLSCHAFT (DE) 1989-08-29 US disclosed
EP-0279425-A2 Use of benzothiazepine derivatives, in particular diltiazem, in the manufacture of medicaments to protect lymphocytes GÖDECKE AKTIENGESELLSCHAFT (DE) 1988-08-24 EP disclosed